Cascade-responsive nanobomb for anti-tumor synergistic therapies

Cascade-responsive nanobomb for anti-tumor synergistic therapies
(a) Synthesis process of ZnO2@Ce6/CaP@CPPO/BSA (Z@Ce6/CaP@CB). (b) Schematic illustration of the mechanism of Z@Ce6/CaP@CB-based synergistic therapy. Z@Ce6/CaP@CB nanobombs can trigger multiple ROS storms and Ca2+ overload-induced cell death through a cascade reaction without external energy activation and effectively activate the systemic immune response while inhibiting the growth of primary tumors. Credit: Science China Press

Reactive oxygen species (ROS) can act as signal carriers during the evolution of malignant tumors. At the appropriate concentration, ROS mediate signal transduction and cell growth. However, ROS are a double-edged sword, as excessive ROS can oxidize proteins, damage the DNA structure, and induce cell apoptosis. Moreover, ROS can induce inflammation at the tumor site, which further improves tumor immunogenicity. Therefore, increasing the content of ROS in tumor sites has become an effective method for cancer therapy. At present, the ways to generate ROS through external stimulations, such as photodynamic reaction, sonodynamic reaction, and radiation sensitization, are greatly limited by the penetration depth of the laser, irradiation range of external excitation, and safety concerns of the radiation.

In response to these problems, chemodynamic therapy has been developed, which has received widespread attention. Chemodynamic therapy uses excess H2O2 in the without external energy stimulation to generate ROS through the Fenton reaction. However, the current therapeutic effect of chemodynamic therapy is not satisfactory, because the initiation of an efficient Fenton reaction requires harsh acidic conditions and excess H2O2. In addition to exogenous ROS production strategies, increasing the generation of endogenous ROS to inhibit growth is another promising approach. It is well known that inhibiting the mitochondrial electron transport chain can enhance the generation of ROS. However, treating cancer only by increasing endogenous ROS is unsatisfactory, as it is difficult to effectively inhibit tumor growth with a low amount of produced endogenous ROS. Therefore, developing strategies for the selective generation of sufficient ROS without external energy stimulation under mild in vivo conditions remains a huge challenge in the field of .

In a new research article published in the Beijing-based National Science Review, scientists at the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, China, designed a cascade-responsive ROS generation device with and without external stimulation for the specific generation of multiple severe ROS storms at the tumor site. Co-authors Yang Liu, Yinghui Wang, Shuyan Song and Hongjie Zhang find that the simple introduction of the prepared ZnO2@Ce6/CaP@CPPO/BSA nanobomb into the tumor would cause a "domino effect", which could trigger the production of multiple ROS storms and Ca2+ overload, as well as effectively activate the systemic immune response while inhibiting the growth of primary tumors. Moreover, tumor metastasis can be effectively prevented by adjuvant treatment with anti-CTLA4 checkpoint blockers.

More information: Yang Liu et al, Cascade-responsive Nanobomb with domino effect for anti-tumor synergistic therapies, National Science Review (2021). DOI: 10.1093/nsr/nwab139

Citation: Cascade-responsive nanobomb for anti-tumor synergistic therapies (2021, October 20) retrieved 26 June 2024 from https://medicalxpress.com/news/2021-10-cascade-responsive-nanobomb-anti-tumor-synergistic-therapies.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Near-infrared synergy therapy for cancer nanoclusters

2 shares

Feedback to editors